Abstract
Timololmaleat, halen glokom ve oküler
hipertansiyon tedavisinde topikaloftalmik bir preparat olarak kullanılan,
seçici olmayan β-adrenoseptör antagonistidir. Bu vakada baş dönmesi ve senkop
ile acil servise başvuran olgunun elektrokardiyografisinde düşük ventrikül
yanıtlı atrial fibrilasyon ve duraklama izlendi. Hastanın göz damlası
kesildiğinde duraklamaların olmadığı görüldü.
Keywords
References
- 1. Nieminen T, Lehtimaki T, Maenpaa J, Ropo A, Uusitalo H, Kahonen M. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. [Review]. 2007;67(2):237-45.
- 2. Rubin Lopez JM, Hevia Nava S, Veganzones Bayon A, Barriales Alvarez V. [Atrioventricular block secondary to topical ophthalmic beta blockers]. Rev Esp Cardiol. [Clinical Trial]. 1999 Jul;52(7):532.
- 3. Chun JG, Brodsky MA, Allen BJ. Syncope, bradycardia, and atrioventricular block associated with topical ophthalmic levobunolol. Am Heart J. [Case Reports]. 1994 Mar;127(3):689-90.
- 4. Ozcan KS, Gungor B, Osmonov D, Tekkesin AI, Altay S, Ekmekci A, et al. Management and outcome of topical beta-blocker-induced atrioventricular block. Cardiovasc J Afr. 2015 Nov-Dec;26(6):210-3.
Abstract
References
- 1. Nieminen T, Lehtimaki T, Maenpaa J, Ropo A, Uusitalo H, Kahonen M. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. [Review]. 2007;67(2):237-45.
- 2. Rubin Lopez JM, Hevia Nava S, Veganzones Bayon A, Barriales Alvarez V. [Atrioventricular block secondary to topical ophthalmic beta blockers]. Rev Esp Cardiol. [Clinical Trial]. 1999 Jul;52(7):532.
- 3. Chun JG, Brodsky MA, Allen BJ. Syncope, bradycardia, and atrioventricular block associated with topical ophthalmic levobunolol. Am Heart J. [Case Reports]. 1994 Mar;127(3):689-90.
- 4. Ozcan KS, Gungor B, Osmonov D, Tekkesin AI, Altay S, Ekmekci A, et al. Management and outcome of topical beta-blocker-induced atrioventricular block. Cardiovasc J Afr. 2015 Nov-Dec;26(6):210-3.
Details
| Subjects | Health Care Administration |
|---|---|
| Journal Section | Articles |
| Authors | |
| Publication Date | August 20, 2017 |
| Submission Date | June 21, 2017 |
| Acceptance Date | July 3, 2017 |
| Published in Issue | Year 2017 Volume: 10 Issue: 2 |
Cite
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.